PROTEXT MOBILITY INC Inactive Instrument
ProText Mobility Inc Stock OTC Bulletin Board
Equities
US74371E1055
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2022 | Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update | CI |
| 2021 | ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility | CI |
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Plooy Du Dylon
CEO | Chief Executive Officer | - | - |
| Chairman | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
Plooy Du Dylon
CEO | Chief Executive Officer | - | - |
Protext Mobility, Inc. is a biotech company, which is engaged in the development of a cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes and technologies. The Company is engaged in the research, testing and development of highly bioavailable botanical products all-natural ingredients formulated for nutraceutical and pharmaceutical applications through the use of proprietary live plant extraction technology. The Companyâs subsidiaries include Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.65% | 104B | |
| +6.75% | 97.47B | |
| +5.71% | 22.25B | |
| -12.60% | 21.68B | |
| -9.70% | 18.2B | |
| -39.98% | 17.02B | |
| -10.17% | 16.36B | |
| +6.12% | 14.39B | |
| +35.47% | 12.37B |
